The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis
Abstract
The decisions made by the National Institute for Clinical Excellence (NICE) give rise to two questions: how is cost‐effectiveness evidence used to make judgements about the ‘value for money’ of health technologies? And how are factors other than cost‐effectiveness taken into account? The aim of this paper is to explore NICE's cost‐effectiveness threshold(s) and the tradeoffs between cost effectiveness and other factors apparent in its decisions. Binary choice analysis is used to reveal the preferences of NICE and to consider the consistency of its decisions. For each decision to accept or reject a technology, explanatory variables include: the cost per life year or per QALY gained; uncertainty regarding cost effectiveness; the net cost to the NHS; the burden of disease; the availability (or not) of alternative treatments; and specific factors indicated by NICE. Results support the broad notion of a threshold, where the probability of rejection increases as the cost per QALY increases. Cost effectiveness, together with uncertainty and the burden of disease, explain NICE decisions better than cost effectiveness alone. The results suggest a threshold somewhat higher than NICEs stated ‘range of acceptable cost effectiveness’ of £20 000–£30 000 per QALY – although the exact meaning of a ‘range’ in this context remains unclear. Copyright © 2004 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Claxton, K. (1999) · Journal of Health Economics · doi:10.1016/s0167-6296(98)00039-3 · Cited by 889
NICE: faster access to modern treatments? Analysis of guidance on health technologies
Raftery, J. (2001) · BMJ · doi:10.1136/bmj.323.7324.1300 · Cited by 299
Is there a kink in consumers' threshold value for cost‐effectiveness in health care?
OʼBrien, B. J., Герцен, К. А., Willan, A. R., & Faulkner, A. (2002) · Health Economics · doi:10.1002/hec.655 · Cited by 155
On being NICE in the UK: guidelines for technology appraisal for the NHS in England and Wales
Birch, S., & Gafni, A. (2002) · Health Economics · doi:10.1002/hec.706 · Cited by 69
Cited by
Registries for Evaluating Patient Outcomes: A User’s Guide
(2020) · doi:10.23970/ahrqepcregistries4 · Cited by 960
The NICE Cost-Effectiveness Threshold: What it is and What that Means
McCabe, C., Claxton, K., & Culyer, A. J. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826090-00004 · Cited by 864
Claxton, K., Martin, S., Soares, M., Rice, N., Spackman, E., Hinde, S., Devlin, N., Smith, P. C., & Sculpher, M. (2015) · Health Technology Assessment · doi:10.3310/hta19140 · Cited by 853
Self-citationAssessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold
Grosse, S. D. (2008) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.8.2.165 · Cited by 637
de la Torre-Díez, I., López-Coronado, M., Vaca, C., Aguado, J. S., & de Castro, C. (2015) · Telemedicine and e-Health · doi:10.1089/tmj.2014.0053 · Cited by 495
Metadata
- Authors
- Devlin, N., & Parkin, D.
- Venue
- Health Economics
- Publisher
- Wiley
- Published
- 2004-01-16
- Volume
- 13
- Issue
- 5
- Pages
- 437-452
- ISSN
- 1057-9230 (ISSN-L)
- 1099-1050
- OpenAlex
- W2020460752
- Cited by
- 709
- References
- 4
- FWCI
- 106.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.